Abstract
The immune system is a sophisticated and complex system that is influenced by various exogenous insults such as surgical stress and endogenous factors like the sympathetic nervous system. It has been demonstrated that sedative agents used in clinical practice alter the balance of pro- and anti-inflammatory cytokines. These effects may be reversible following short exposure to anaesthetic agents and sedative drugs. However, many critically ill patients are sedated for prolonged periods of time, which raises concerns about the risks of immunological interference by sedative agents. When one considers that sepsis accounts for significant morbidity in intensive care, it is imperative that anything modifiable which causes immunosuppression is identified. The systemic inflammatory response syndrome is known to feature an increase in pro-inflammatory mediators, something which could be influenced by sedative agents.
We propose to outline the details surrounding this area, focusing on sedative agents commonly used in the intensive care setting. A more detailed understanding of this area could lead to improved patient outcomes and have far-reaching influence on clinical practice in critical care.
Keywords: Critical care, sedation, immunosuppression, immunomodulation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: The Immunological Side-Effects of Sedative Agents in the Intensive Care Unit
Volume: 9 Issue: 3
Author(s): A. Walsh and K. Ghori
Affiliation:
Keywords: Critical care, sedation, immunosuppression, immunomodulation
Abstract: The immune system is a sophisticated and complex system that is influenced by various exogenous insults such as surgical stress and endogenous factors like the sympathetic nervous system. It has been demonstrated that sedative agents used in clinical practice alter the balance of pro- and anti-inflammatory cytokines. These effects may be reversible following short exposure to anaesthetic agents and sedative drugs. However, many critically ill patients are sedated for prolonged periods of time, which raises concerns about the risks of immunological interference by sedative agents. When one considers that sepsis accounts for significant morbidity in intensive care, it is imperative that anything modifiable which causes immunosuppression is identified. The systemic inflammatory response syndrome is known to feature an increase in pro-inflammatory mediators, something which could be influenced by sedative agents.
We propose to outline the details surrounding this area, focusing on sedative agents commonly used in the intensive care setting. A more detailed understanding of this area could lead to improved patient outcomes and have far-reaching influence on clinical practice in critical care.
Export Options
About this article
Cite this article as:
Walsh A. and Ghori K., The Immunological Side-Effects of Sedative Agents in the Intensive Care Unit, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2010; 9 (3) . https://dx.doi.org/10.2174/1871523011009030229
DOI https://dx.doi.org/10.2174/1871523011009030229 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Medical Hypothermia-A Multispecialty Approach
Recent Patents on Cardiovascular Drug Discovery Essential Oils and Alcohol Extracts of Northwest Tunisia <i>M. communis</i> and <i>M. spicata</i>: Phytocompounds, Antioxidant and Antibacterial Activities
Current Bioactive Compounds Subject Index To Volume 4
Current Vascular Pharmacology Metal Complexes, their Cellular Targets and Potential for Cancer Therapy
Current Pharmaceutical Design An Overview on Natural Cholinesterase Inhibitors - A Multi-Targeted Drug Class - and Their Mass Production
Mini-Reviews in Medicinal Chemistry Engineered Nanoparticles for Improved Vasoactive Intestinal Peptide (VIP) Biomedical Applications
Recent Patents on Nanomedicine Left Ventricular Hypertrophy in Isolated Aortic Stenosis: Primetime for the Ventricle
Current Pharmaceutical Biotechnology The Therapeutic Potential and Usage Patterns of Cannabinoids in People with Spinal Cord Injuries: A Systematic Review
Current Neuropharmacology Sesame Seed Lignans: Potent Physiological Modulators and Possible Ingredients in Functional Foods & Nutraceuticals
Recent Patents on Food, Nutrition & Agriculture Agents Targeting Ras Signaling Pathway
Current Pharmaceutical Design Cannabinoids and Cardiovascular Disease: The Outlook for Clinical Treatments
Current Vascular Pharmacology Hydrogen Sulfide and its Modulation in Arterial Hypertension and Atherosclerosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Recent Advances in the Development of 14-Alkoxy Substituted Morphinans as Potent and Safer Opioid Analgesics
Current Medicinal Chemistry Targeting Small Arteries of Hypertensive Status with Novel ATP-Sensitive Potassium Channel Openers&#
Current Vascular Pharmacology Heterocyclic Chalcone Analogues as Potential Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Role of Membrane Transporters and Metabolizing Enzymes in Ocular Drug Delivery
Current Drug Metabolism COVID-19: An Opinion of Prevention and Dietary Based Management Hypothesis
Coronaviruses Sepsis-induced Cardiomyopathy
Current Cardiology Reviews Tear Film, Conjunctival and Corneal Modifications Induced by Glaucoma Treatment
Current Medicinal Chemistry Is the Cytoskeleton an Intracellular Receptor for Adrenomedullin and PAMP?
Current Protein & Peptide Science